Citation: | HOU Baojie, YUAN Ping. Nasopharyngeal cancer disease burden and equity study in China in 1990 and 2017[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(3): 323-328. doi: 10.16462/j.cnki.zhjbkz.2024.03.012 |
[1] |
Song YX, Cheng WW, Li HQ, et al. The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990-2019) and predictions to 2035[J]. Cancer Med, 2022, 11(22): 4310-4320. DOI: 10.1002/cam4.4783.
|
[2] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
[3] |
Zhang RH, He YF, Wei BC, et al. Nasopharyngeal carcinoma burden and its attributable risk factors in China: estimates and forecasts from 1990 to 2050[J]. Int J Environ Res Public Health, 2023, 20(4): 2926. DOI: 10.3390/ijerph20042926.
|
[4] |
Organization WH. Handbook on health inequality monitoring with a special focus on low- and middle-income countries[M]. Geneva: WHO press, 2013: 6-55.
|
[5] |
Yang D, Bin NF, Zhou ZY, et al. Demographics and economic burden of nasopharyngeal carcinoma inpatients[J]. Biomed Res Int, 2022, 2022: 6958806. DOI: 10.1155/2022/6958806.
|
[6] |
Zhou MG, Wang HD, Zeng XY, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. DOI: 10.1016/S0140-6736(19)30427-1.
|
[7] |
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1923-1994. DOI: 10.1016/S0140-6736(18)32225-6.
|
[8] |
GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053): 1603-1658. DOI: 10.1016/S0140-6736(16)31460-X.
|
[9] |
刘岩. 河南省肺癌时空分布特征及环境因素影响研究[D]. 郑州: 郑州大学, 2022: 24-25.
Liu Y. Study on the spatio-temporal distribution of lung cancer and the influence of environmental factors in Henan province[D]. Zhengzhou: Zhengzhou University, 2022: 24-25.
|
[10] |
宋宁娟, 谢昀, 丁晟, 等. 江西省2013—2018年肾综合征出血热空间自相关分析[J]. 中华疾病控制杂志, 2020, 24(8): 876-880. DOI: 10.16462/j.cnki.zhjbkz.2020.08.003.
Song NJ, Xie Y, Ding S, et al. Spatial autocorrelation analysis of hemorrhagic fever with renal syndrome in Jiangxi province from 2013 to 2018[J]. Chin J Dis Control Prev, 2020, 24(8): 876-880. DOI: 10.16462/j.cnki.zhjbkz.2020.08.003.
|
[11] |
Hyldgard VB, Johnsen SP, Sogaard R. Index-based inequality in quality of care: an empirical comparison of apples and pears[J]. Clin Epidemiol, 2021, 13: 791-800. DOI: 10.2147/CLEP.S311813.
|
[12] |
Cao F, He YS, Wang Y, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019[J]. Autoimmun Rev, 2023, 22(6): 103326. DOI: 10.1016/j.autrev.2023.103326.
|
[13] |
高忠飞. 宁夏医改项目县农村居民卫生服务公平性动态变化研究[D]. 银川: 宁夏医科大学, 2017: 5-6.
Gao ZF. Study on dynamic change of health service equity of rural residents in Ningxia medical reform project counties[D]. Yinchuan: Ningxia Medical University, 2017: 5-6.
|
[14] |
徐媛媛, 曾新颖, 邱琇, 等. 中国儿童青少年缺铁性贫血疾病负担及健康公平性分析[J]. 中国妇幼健康研究, 2021, 32(6): 830-837. DOI: 10.3969/j.issn.1673-5293.2021.06.011.
Xu YY, Zeng XY, Qiu X, et al. Analysis on disease burden and health equity of iron-deficiency anemia among children and adolescents in China[J]. Chinese Journal of Woman and Child Health Research, 2021, 32(6): 830-837. DOI: 10.3969/j.issn.1673-5293.2021.06.011.
|
[15] |
Yu H, Yin X, Mao Y, et al. The global burden of nasopharyngeal carcinoma from 2009 to 2019: an observational study based on the Global Burden of Disease Study 2019[J]. Eur Arch Otorhinolaryngol, 2022, 279(3): 1519-1533. DOI: 10.1007/s00405-021-06922-2.
|
[16] |
梁宇卿, 陈宏达, 喻达. 恶性肿瘤防治规划和防治策略的经验借鉴[J]. 癌症进展, 2021, 19(17): 1736-1739. DOI: 10.11877/j.issn.1672-1535.2021.19.17.03.
Liang YQ, Chen HD, Yu D. The experience of planning and strategy for prevention and treatment of malignant tumor[J]. Cancer progression, 2021, 19(17): 1736-1739. DOI: 10.11877/j.issn.1672-1535.2021.19.17.03.
|